Delivery of Care
Immunotherapy toxicities demand a joined up approach from oncologists and organ specialists
Adverse effects of cancer therapies have long been at the root of decision making for interventions in all modalities – surgery, radiotherapy and medical – and especially in the latter…
Who wouldn’t want to cure 100% of childhood cancers?
More than eight in ten children and young adults diagnosed with cancer now survive their disease, often going on to live long and fulfilling lives. But the serious life-long damage…
Berlin pilot project brings precision care to the peripheries
An innovative network in Germany is giving men with advanced prostate cancer access to cutting-edge precision medicine – even if they live in remote areas. Patient organisations are wondering whether…
EMA at 25: learning more from cancer patients
The European Medicines Agency is 25 years old this year. To mark the occasion, the agency invited leading voices from parts of the cancer community to share their perspectives on…
Their fingers on the button: why neglecting radiation therapists is no longer an option
Can you be sure that the person who positions you on the radiotherapy table and delivers your prescribed dose has received the necessary training and education? Europe’s radiation therapist profession…
Delivering cancer care during the pandemic: lessons from the ‘first wave’
As the COVID-19 pandemic shows signs of an autumn resurgence, we look at how the ‘first wave’ impacted on the delivery of cancer care, and review responses to the Cancer…
Raed Al Dieri: Taking pathology from bit part to key player on the European oncology scene
With precision medicine, pathology has moved out of the labs and into the heart of clinical decision making. But the discipline still struggles to make its voice heard at the…
Will artificial intelligence revolutionise cancer therapeutics and care?
AI has started to impact oncology, with tools for quicker and more-accurate diagnostics, but its role in better interpreting genomic data is still to be realised. Rachel Brazil pinpoints the…
Prognostic biomarkers: could they help doctors, patients and families to better navigate the end of life?
“We had to explain that the reason she had broken her hip was because she was getting weaker and essentially dying… At that stage knowing whether Mum had days or…
Rare cancer care: Are European Reference Networks delivering on the promise?
With a bigger role for European Reference Networks foreseen for Europe’s post-pandemic future, we ask: are they fulfilling their mandate to improve the quality of diagnostics and care for patients…